Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China.
Zi-Xiao LiXin-Miao ZhangLingling DingJing JingHong-Qiu GuYong JiangXia MengChunying DuChunjuan WangMeng WangMan XuYanxu ZhangMeera HuHao LiXiping GongKehui DongXing-Quan ZhaoYilong WangLi-Ping LiuYing XianEric PetersonGregg C FonarowLee H SchwammYong-Jun WangPublished in: Stroke and vascular neurology (2023)
NCT04524624.
Keyphrases
- artificial intelligence
- clinical decision support
- study protocol
- clinical trial
- randomized controlled trial
- machine learning
- big data
- quality improvement
- electronic health record
- deep learning
- open label
- phase iii
- phase ii
- healthcare
- atrial fibrillation
- palliative care
- double blind
- placebo controlled
- pain management
- type diabetes
- cerebral ischemia
- skeletal muscle
- chronic pain
- brain injury
- glycemic control